Clearpoint Neuro Inc CLPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:11 PM EDT
5.94quote price arrow up+0.07 (+1.19%)
Volume
1,845
Close
5.87quote price arrow up+0.35 (+6.34%)
Volume
72,759
52 week range
4.05 - 9.87
Loading...
  • Open5.59
  • Day High5.88
  • Day Low5.59
  • Prev Close5.52
  • 52 Week High9.87
  • 52 Week High Date05/11/23
  • 52 Week Low4.05
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap158.898M
  • Shares Out27.07M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change-13.55

KEY STATS

  • Open5.59
  • Day High5.88
  • Day Low5.59
  • Prev Close5.52
  • 52 Week High9.87
  • 52 Week High Date05/11/23
  • 52 Week Low4.05
  • 52 Week Low Date11/10/23
  • Market Cap158.898M
  • Shares Out27.07M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change-13.55

RATIOS/PROFITABILITY

  • EPS (TTM)-0.90
  • P/E (TTM)-6.54
  • Fwd P/E (NTM)-7.72
  • EBITDA (TTM)-21.82M
  • ROE (TTM)-76.09%
  • Revenue (TTM)23.955M
  • Gross Margin (TTM)56.83%
  • Net Margin (TTM)-92.21%
  • Debt To Equity (MRQ)46.99%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Clearpoint Neuro Inc

 

Profile

MORE
ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed...
R. John Fletcher
Independent Chairman of the Board
Joseph Burnett
President, Chief Executive Officer, Director
Mazin Sabra
Chief Operating Officer
Danilo D' Alessandro
Chief Financial Officer
Jeremy Stigall
Executive Vice President, General Manager of Biologics & Drug Delivery
Ellisa Cholapranee J.D.
General Counsel, Secretary
Address
120 S. SIERRA AVENUE, SUITE 100
Solana Beach, CA
92075
United States

Top Peers

SYMBOLLASTCHG%CHG
SEER
Seer Inc
2.24+0.08+3.70%
STXS
Stereotaxis Inc
2.34+0.02+0.86%
MYO
Myomo Inc
3.76-0.16-4.08%
KRMD
KORU Medical Systems Inc
2.32-0.06-2.52%
SRTS
Sensus Healthcare Inc
3.65-0.21-5.44%